DUENOR Trademark

Trademark Overview

On Monday, May 12, 2008, a trademark application was filed for DUENOR with the United States Patent and Trademark Office. The USPTO has given the DUENOR trademark a serial number of 77471479. The federal status of this trademark filing is ABANDONED - NO STATEMENT OF USE FILED as of Monday, July 16, 2012. This trademark is owned by Glaxo Group Limited. The DUENOR trademark is filed in the Pharmaceutical Products category with the following description:

Pharmaceutical preparations and substances for the treatment of infectious diseases, blood disorders, pain, inflammation, sepsis, alopecia, obesity and cognitive disorders; Pharmaceutical preparations and substances for the treatment of viral, metabolic, endocrine, musculoskeletal, cardiovascular, cardiopulmonary, genitourinary, sexual dysfunction, oncological, hepatological, ophthalmic, respiratory, neurological, gastrointestinal, hormonal, dermatological, psychiatric and immune system related diseases and disorders; Pharmaceutical preparations and substances for the treatment of damaged skin and tissue; and for vaccines
duenor

General Information

Serial Number77471479
Word MarkDUENOR
Filing DateMonday, May 12, 2008
Status606 - ABANDONED - NO STATEMENT OF USE FILED
Status DateMonday, July 16, 2012
Registration Number0000000
Registration DateNOT AVAILABLE
Mark Drawing4000 - Illustration: Drawing with word(s) / letter(s) / number(s) in Block form
Published for Opposition DateTuesday, March 24, 2009

Trademark Statements

Goods and ServicesPharmaceutical preparations and substances for the treatment of infectious diseases, blood disorders, pain, inflammation, sepsis, alopecia, obesity and cognitive disorders; Pharmaceutical preparations and substances for the treatment of viral, metabolic, endocrine, musculoskeletal, cardiovascular, cardiopulmonary, genitourinary, sexual dysfunction, oncological, hepatological, ophthalmic, respiratory, neurological, gastrointestinal, hormonal, dermatological, psychiatric and immune system related diseases and disorders; Pharmaceutical preparations and substances for the treatment of damaged skin and tissue; and for vaccines
Translation of Words in MarkThe wording "DUENOR" has no meaning in a foreign language.

Classification Information

International Class005 - Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes; dietetic substances adapted for medical use, food for babies; plasters, materials for dressings; material for stopping teeth, dental wax; disinfectants; preparations for destroying vermin; fungicides, herbicides.
US Class Codes006, 018, 044, 046, 051, 052
Class Status Code6 - Active
Class Status DateThursday, May 15, 2008
Primary Code005
First Use Anywhere DateNOT AVAILABLE
First Use In Commerce DateNOT AVAILABLE

Trademark Owner History

Party NameGlaxo Group Limited
Party Type20 - Owner at Publication
Legal Entity Type03 - Corporation
AddressGreenford, Middlesex UB6ONN
Party NameGlaxo Group Limited
Party Type10 - Original Applicant
Legal Entity Type03 - Corporation
AddressGreenford, Middlesex UB6ONN

Trademark Events

Event DateEvent Description
Monday, July 16, 2012ABANDONMENT NOTICE MAILED - NO USE STATEMENT FILED
Monday, July 16, 2012ABANDONMENT - NO USE STATEMENT FILED
Saturday, December 10, 2011NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Friday, December 9, 2011EXTENSION 5 GRANTED
Tuesday, December 6, 2011EXTENSION 5 FILED
Tuesday, December 6, 2011TEAS EXTENSION RECEIVED
Thursday, June 16, 2011NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Wednesday, June 15, 2011EXTENSION 4 GRANTED
Friday, June 10, 2011EXTENSION 4 FILED
Friday, June 10, 2011TEAS EXTENSION RECEIVED
Wednesday, November 3, 2010NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Tuesday, November 2, 2010EXTENSION 3 GRANTED
Thursday, October 21, 2010EXTENSION 3 FILED
Thursday, October 21, 2010TEAS EXTENSION RECEIVED
Wednesday, June 16, 2010NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Tuesday, June 15, 2010EXTENSION 2 GRANTED
Monday, May 24, 2010EXTENSION 2 FILED
Monday, June 14, 2010CASE ASSIGNED TO INTENT TO USE PARALEGAL
Monday, May 24, 2010TEAS EXTENSION RECEIVED
Thursday, May 13, 2010TEAS CHANGE OF CORRESPONDENCE RECEIVED
Monday, May 3, 2010TEAS CHANGE OF CORRESPONDENCE RECEIVED
Monday, February 22, 2010ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
Monday, February 22, 2010TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
Thursday, December 3, 2009EXTENSION 1 GRANTED
Thursday, December 3, 2009EXTENSION 1 FILED
Thursday, December 3, 2009TEAS EXTENSION RECEIVED
Tuesday, June 16, 2009NOA MAILED - SOU REQUIRED FROM APPLICANT
Tuesday, March 24, 2009PUBLISHED FOR OPPOSITION
Wednesday, March 4, 2009NOTICE OF PUBLICATION
Thursday, February 19, 2009LAW OFFICE PUBLICATION REVIEW COMPLETED
Wednesday, February 18, 2009APPROVED FOR PUB - PRINCIPAL REGISTER
Thursday, February 5, 2009TEAS/EMAIL CORRESPONDENCE ENTERED
Thursday, February 5, 2009CORRESPONDENCE RECEIVED IN LAW OFFICE
Thursday, February 5, 2009ASSIGNED TO LIE
Wednesday, February 4, 2009TEAS RESPONSE TO OFFICE ACTION RECEIVED
Monday, August 25, 2008NOTIFICATION OF NON-FINAL ACTION E-MAILED
Monday, August 25, 2008NON-FINAL ACTION E-MAILED
Monday, August 25, 2008NON-FINAL ACTION WRITTEN
Monday, August 25, 2008ASSIGNED TO EXAMINER
Thursday, May 15, 2008NEW APPLICATION ENTERED IN TRAM

Related Keywords

duenor pharmaceutical treatment substances disorders preparations diseases hormonal neurological gastrointestinal ophthalmic